BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Esposito S, Polinori I, Rigante D. The Gut Microbiota-Host Partnership as a Potential Driver of Kawasaki Syndrome. Front Pediatr 2019;7:124. [PMID: 31024869 DOI: 10.3389/fped.2019.00124] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Venegas-Borsellino C, Sankararaman S, Roche K, Burns J, Landis RM. Impact of COVID-19 on the Intestinal Microbiome. Curr Nutr Rep 2021;10:300-6. [PMID: 34813042 DOI: 10.1007/s13668-021-00375-z] [Reference Citation Analysis]
2 Li S, Yang S, Zhou Y, Disoma C, Dong Z, Du A, Zhang Y, Chen Y, Huang W, Chen J, Song D, Chen Z, Liu P, Li S, Zheng R, Liu S, Razzaq A, Chen X, Tao S, Yu C, Feng T, Liao W, Peng Y, Jiang T, Huang J, Wu W, Hu L, Wang L, Li S, Xia Z. Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota. Front Microbiol 2021;12:712081. [PMID: 34707577 DOI: 10.3389/fmicb.2021.712081] [Reference Citation Analysis]
3 Kaneko K, Akagawa S, Akagawa Y, Kimata T, Tsuji S. Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota. Front Immunol 2020;11:1616. [PMID: 32793240 DOI: 10.3389/fimmu.2020.01616] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bossù G, Di Sario R, Argentiero A, Esposito S. Antimicrobial Prophylaxis and Modifications of the Gut Microbiota in Children with Cancer. Antibiotics (Basel) 2021;10:152. [PMID: 33546312 DOI: 10.3390/antibiotics10020152] [Reference Citation Analysis]
5 Mancabelli L, Milani C, Fontana F, Lugli GA, Tarracchini C, Turroni F, van Sinderen D, Ventura M. Mapping bacterial diversity and metabolic functionality of the human respiratory tract microbiome. J Oral Microbiol 2022;14:2051336. [PMID: 35309410 DOI: 10.1080/20002297.2022.2051336] [Reference Citation Analysis]
6 Shen J, Ding Y, Yang Z, Zhang X, Zhao M. Effects of changes on gut microbiota in children with acute Kawasaki disease. PeerJ 2020;8:e9698. [PMID: 33005487 DOI: 10.7717/peerj.9698] [Reference Citation Analysis]
7 Isidori C, Sebastiani L, Esposito S. A Case of Incomplete and Atypical Kawasaki Disease Presenting with Retropharyngeal Involvement. Int J Environ Res Public Health 2019;16:E3262. [PMID: 31491922 DOI: 10.3390/ijerph16183262] [Reference Citation Analysis]
8 Williams V, Dash N, Suthar R, Mohandoss V, Jaiswal N, Kavitha T, Nallasamy K, Angurana SK. Clinicolaboratory Profile, Treatment, Intensive Care Needs, and Outcome of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: A Systematic Review and Meta-analysis. J Pediatr Intensive Care. [DOI: 10.1055/s-0040-1719173] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Barbara Z, Ellenwood SP, Loe ED, Choi J, Ryan K, Joseph N. Kawasaki Disease Complicated by Salmonella oranienburg Coinfection. Case Rep Pediatr 2021;2021:5584514. [PMID: 33936828 DOI: 10.1155/2021/5584514] [Reference Citation Analysis]
10 Rhim JW, Kang HM, Han JW, Lee KY. A Presumed Etiology of Kawasaki Disease Based on Epidemiological Comparison With Infectious or Immune-Mediated Diseases. Front Pediatr 2019;7:202. [PMID: 31165053 DOI: 10.3389/fped.2019.00202] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
11 Hu C, Yu Y. Gastrointestinal hemorrhage before anticoagulant therapy in Kawasaki disease: a case report. BMC Pediatr 2020;20. [DOI: 10.1186/s12887-020-1916-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Tariq S, Clifford AH. An update on the microbiome in vasculitis. Curr Opin Rheumatol 2021;33:15-23. [PMID: 33186243 DOI: 10.1097/BOR.0000000000000758] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Rigante D. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection. Mediterr J Hematol Infect Dis 2020;12:e2020039. [PMID: 32670517 DOI: 10.4084/MJHID.2020.039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
14 Chang L, Yang HW, Lin TY, Yang KD. Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease. Front Pediatr 2021;9:697632. [PMID: 34350146 DOI: 10.3389/fped.2021.697632] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Zhou Y, Zhang M, Zhao X, Feng J. Ammonia exposure induced intestinal inflammation injury mediated by intestinal microbiota in broiler chickens via TLR4/TNF-α signaling pathway. Ecotoxicol Environ Saf 2021;226:112832. [PMID: 34583273 DOI: 10.1016/j.ecoenv.2021.112832] [Reference Citation Analysis]
16 Kang K, Sun Y, Li YL, Chang B. Pathogenesis of liver injury in Takayasu arteritis: advanced understanding leads to new horizons. J Int Med Res 2020;48:300060520972222. [PMID: 33275473 DOI: 10.1177/0300060520972222] [Reference Citation Analysis]
17 Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, Newburger JW, Kleinman LC, Heidemann SM, Martin AA, Singh AR, Li S, Tarquinio KM, Jaggi P, Oster ME, Zackai SP, Gillen J, Ratner AJ, Walsh RF, Fitzgerald JC, Keenaghan MA, Alharash H, Doymaz S, Clouser KN, Giuliano JS Jr, Gupta A, Parker RM, Maddux AB, Havalad V, Ramsingh S, Bukulmez H, Bradford TT, Smith LS, Tenforde MW, Carroll CL, Riggs BJ, Gertz SJ, Daube A, Lansell A, Coronado Munoz A, Hobbs CV, Marohn KL, Halasa NB, Patel MM, Randolph AG;  Overcoming COVID-19 Investigators;  CDC COVID-19 Response Team. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020;383:334-346. [PMID: 32598831 DOI: 10.1056/nejmoa2021680] [Cited by in Crossref: 753] [Cited by in F6Publishing: 407] [Article Influence: 376.5] [Reference Citation Analysis]
18 Konig MF. The microbiome in autoimmune rheumatic disease. Best Pract Res Clin Rheumatol 2020;34:101473. [PMID: 32044247 DOI: 10.1016/j.berh.2019.101473] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
19 van der Lelie D, Taghavi S. COVID-19 and the Gut Microbiome: More than a Gut Feeling. mSystems. 2020;5. [PMID: 32694127 DOI: 10.1128/msystems.00453-20] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
20 Hicar MD. Antibodies and Immunity During Kawasaki Disease. Front Cardiovasc Med 2020;7:94. [PMID: 32671098 DOI: 10.3389/fcvm.2020.00094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Fukazawa M, Fukazawa M, Nanishi E, Nishio H, Ichihara K, Ohga S. Previous antibiotic use and the development of Kawasaki disease: a matched pair case‐control study. Pediatrics International 2020;62:1044-8. [DOI: 10.1111/ped.14255] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]